Recent news on Insulin Aspart

Hypoglycemia: Answering the Challenge With Long-acting Insulin Analogs  -  May 18, 2007
Medscape (subscription)Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for

Insulin therapy for diabetes  -  May 16, 2007
Chennai Online,Novolog (Novo; FDA approved in 2001) (insulin aspart) is made by replacing B28 proline with aspartic acid. Apidra (Sanofi-Aventis; FDA approved in 2004)

Modern insulin approved for pregnant w diabetes  -  Apr 30, 2007
Scoop.co.nz,Hypoglycaemia with insulin aspart: a double blind, randomised, crossover trial in subjects with type 1 diabetes. Diabet Med 2004; 21(7): 769-775

Exenatide Similar to Insulin in Reducing Blood Glucose, but Also ...  -  Apr 26, 2007
DG News...was administered as a fixed 10 mcg dose BID, and insulin was titrated regularly and administered QD (insulin glargine) or BID (biphasic insulin aspart).

New injectable treatment for type II diabetes  -  Apr 26, 2007
Healthcare RepublicThe efficacy of exenatide has also been compared to insulin glargine 4 and insulin aspart 5 in patients that are inadequately controlled with metformin and

Exenatide Similar to Insulin in Reducing Blood Glucose, but Also ...  -  26 Apr 2007
DG News...was administered as a fixed 10 mcg dose BID, and insulin was titrated regularly and administered QD (insulin glargine) or BID (biphasic insulin aspart).

New injectable treatment for type II diabetes  -  26 Apr 2007
Healthcare RepublicThe efficacy of exenatide has also been compared to insulin glargine 4 and insulin aspart 5 in patients that are inadequately controlled with metformin and

New Data Confirm That Use Of Levemir® Can Limit Weight Gain  -  Apr 23, 2007
Medical News Today (press release),Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal bolus therapy for

Insulin Analogs or Premixed Insulin Analogs in Combination With ...  -  Apr 17, 2007
Medscape (subscription)Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes. Diabetologia.

Managing diabetes is now simpler and more convenient with new ...  -  Apr 3, 2007
CNW Telbec (Communiqués de presse),1), (2) Now available in Canada, NovoMix(R) 30 (biphasic insulin aspart) is a premixed insulin analogue indicated for adults affected by diabetes that is a

Levemir® Approved In Europe For Use In Combination With Oral ...  -  Mar 12, 2007
Medical News Today (press release),Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal bolus therapy for

Evolution of a Pulmonary Insulin Delivery System for Patients With ...  -  Mar 6, 2007
Medscape (subscription)Onset of action of inhaled insulin via the AERx iDMS was faster than subcutaneous human regular insulin and similar to that of subcutaneous insulin aspart.

FDA Approves NovoLog(R) (Insulin Aspart [rDNA Origin] Injection ...  -  Jan 30, 2007
DG NewsNovoLog(R) is contraindicated during episodes of hypoglycemia and in people hypersensitive to insulin aspart or one of its excipients.

FDA Approves NovoLog(R) Category Change For Use In Pregnant Women ...  -  Jan 31, 2007
Medical News Today (press release),Novo Nordisk announced today that the United States Food and Drug Administration (FDA) has approved NovoLog(R) (insulin aspart [rDNA origin] injection) for

NovoLog Receives Pregnancy Category B Rating  -  Jan 31, 2007
Facts and Comparisons,The FDA has approved Novo Nordisk’s NovoLog (insulin aspart [rDNA origin]) injection with a pregnancy Category B rating. Adequate studies conducted in

Nastech Announces Positive Phase 1 Clinical Results of Insulin ...  -  Dec 6, 2006
Drug Newswire (press release),With respect to plasma insulin levels, rapid-acting insulin aspart injection had the highest concentration, followed by the three nasal formulations,

Market Report -- In Play (NSTK)  -  Dec 6, 2006
MSN MoneyNastech Pharm announces positive Phase 1 clinical results of Insulin Nasal Spray compared to Exubera inhalation powder and NovoLog insulin Aspart Co

Sección internacional  -  Dec 6, 2006
Bolsamania.com,...(PRN) - Nastech Announces Positive Phase 1 Clinical Results of Insulin Nasal Spray Compared to Exubera(R) Inhalation Powder and NovoLog(C) Insulin Aspart

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional